tert-Butyl substituted aza-BODIPY-based bromides for phototherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Luminescence and Fluorescent Materials · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (59)
Show source-provided references
1. Ultra-Small nano-assemblies as tumor-targeted and renal clearable theranostic agent for photodynamic therapy
2. Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical10.1038/s41467-022-33924-3 ↗
3. A host–guest strategy for converting the photodynamic agents from a singlet oxygen generator to a superoxide radical generator10.1039/D2SC01469F ↗
4. Mitochondria-Targeted photodynamic cancer therapy of nanoscale liposome-encapsulating boron dipyrromethene photosensitizers conjugated with pyridine cations10.1021/acsanm.2c00451 ↗
5. Functional two-photon cationic targeted photosensitizers for deep-seated tumor imaging and therapy10.1016/j.snb.2019.127310 ↗
6. The main strategies for tuning BODIPY fluorophores into photosensitizers10.1142/S1088424619300234 ↗
7. A lysosome-targeted BODIPY as potential NIR photosensitizer for photodynamic therapy10.1016/j.dyepig.2017.07.048 ↗
8. Acceptor-donor-acceptor structured deep-red AIE photosensitizer: lysosome-specific targeting,in vivolong-term imaging, and effective photodynamic therapy10.1016/j.cej.2021.132638 ↗
9. Adipocyte-Targeting type I AIE photosensitizer for obesity treatment via photodynamic lipid peroxidation10.1021/acsnano.3c03654 ↗
10. Activatable photosensitizers: agents for selective photodynamic therapy
11. Anti-inflammatory strategies for photothermal therapy of cancer10.1039/D3TB00839H ↗
12. Activatable photothermal agents with target-initiated large spectral separation for highly effective reduction of side effects10.1039/D2SC02467E ↗
13. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
14. Molecular engineering of pH-responsive NIR oxazine assemblies for evoking tumor ferroptosis via triggering lysosomal dysfunction10.1021/jacs.2c13222 ↗
15. Utilizing intramolecular photoinduced electron transfer to enhance photothermal tumor treatment of aza-BODIPY-based near-infrared nanoparticles10.1021/acsami.8b03568 ↗
16. A dual-targeted organic photothermal agent for enhanced photothermal therapy10.1002/anie.201811273 ↗
17. Near-infrared aza-BODIPY dyes through molecular surgery for enhanced photothermal and photodynamic antibacterial therapy10.1007/s40242-021-1190-7 ↗
18. Rational design of BODIPY organic nanoparticles for enhanced photodynamic/photothermal therapy10.1016/j.dyepig.2018.10.037 ↗
19. A pH-activatable and aniline-substituted photosensitizer for near-infrared cancer theranostics10.1039/C5SC01721A ↗
20. Near infrared boron dipyrromethene nanoparticles for optotheranostics10.1002/smtd.201700370 ↗
21. Tailored engineering of novel xanthonium polymethine dyes for synergetic PDT and PTT triggered by 1064 nm laser toward deep-seated tumors10.1002/smll.202100398 ↗
22. Unadulterated BODIPY nanoparticles for biomedical applications10.1016/j.ccr.2019.04.001 ↗
23. Advances in improving healthcare with aggregation-induced emission10.1002/adhm.202102499 ↗
24. Choline phosphate lipid-hitchhiked near-infrared BODIPY nanoparticles for enhanced phototheranostics10.1039/D3TB00175J ↗
25. Cardiolipin-Targeted NIR-II fluorophore causes “avalanche effects” for Re-engaging cancer apoptosis and inhibiting metastasis10.1021/jacs.2c08602 ↗
26. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
27. Near-infrared light triggered H2 generation for enhanced photothermal/photodynamic therapy against hypoxic tumor10.1002/adhm.202101449 ↗
28. Conformationally restricted aza-bodipy: a highly fluorescent, stable, near-infrared-absorbing dye10.1002/anie.200461868 ↗
29. Structural modification strategies for the rational design of red/NIR region BODIPYs10.1039/C4CS00030G ↗
30. Bioapplications of small molecule Aza-BODIPY: from rational structural design to in vivo investigations10.1039/D0CS00234H ↗
31. Aromatic [b]-fused BODIPY dyes as promising near-infrared dyes10.1039/D0OB00790K ↗
32. Improving the fluorescence brightness of distyryl Bodipys by inhibiting the twisted intramolecular charge transfer excited state10.1039/D1CC03360C ↗
33. Imaging of intracellular singlet oxygen with bright BODIPY dyes10.1016/j.dyepig.2021.109158 ↗
34. Synthesis of BF2 chelates of tetraarylazadipyrromethenes and evidence for their photodynamic therapeutic behaviour10.1039/B204317C ↗
35. Evolution of BODIPY/aza-BODIPY dyes for organic photoredox/energy transfer catalysis10.1016/j.ccr.2022.214698 ↗
36. A facile way to obtain near-infrared room-temperature phosphorescent soft materials based on Bodipy dyes10.1039/C9SC05502A ↗
37. Evolution of BODIPY as triplet photosensitizers from homogeneous to heterogeneous: the strategies of functionalization to various forms and their recent applications10.1016/j.ccr.2023.215074 ↗
38. Rational design of ratiometric near-infrared aza-BODIPY-based fluorescent probe forin VivoImaging of endogenous hydrogen peroxide10.1021/acsabm.9b00842 ↗
39. A molecular recognition platform for the simultaneous sensing of diverse chemical weapons10.1039/D2SC00299J ↗
40. BODIPY-based metal–organic frameworks as efficient electrochemiluminescence emitters for telomerase detection10.1039/D2CC04722E ↗
41. Activatable BODIPY-chromene NIR-II probes with small spectral crosstalk enable high-contrast in vivo bioimaging10.1039/D3CC01742G ↗
42. Self-assembled boron dipyrromethene-based nanocarriers with encapsulated doxorubicin for chemo-photodynamic therapy10.1016/j.dyepig.2022.110679 ↗
43. BODIPY 493 acts as a bright buffering fluorogenic probe for super-resolution imaging of lipid droplet dynamics10.1016/j.cclet.2022.03.120 ↗
44. A molecular design strategy toward enzyme-activated probes with near-infrared I and II fluorescence for targeted cancer imaging10.1039/C9SC02093D ↗
45. Synthesis, photophysical properties, and laser behavior of 3-amino and 3-acetamido BODIPY dyes10.1021/ol701674b ↗
46. An unexpected boron rearrangement leads to a fluorogenic and colorimetric BODIPY probe10.1002/adom.202202601 ↗
47. Synthesis and properties of BF2-3,3′-dimethyldiarylazadipyrromethene near-infrared fluorophores10.1021/ol401434c ↗
48. Effect of the aza-N-bridge and push–pull moieties: a comparative study between BODIPYs and aza-BODIPYs10.1021/acs.joc.1c02525 ↗
49. Non-aryl substituted aza-BODIPYs at 1,7- or 3,5-sites: synthesis, structures, optical properties, and applications10.1039/D2TC05048J ↗
50. Attachment of −tBu groups to aza-BODIPY core at 3,5-sites with ultra-large Stokes shift to enhance photothermal therapy through apoptosis mechanism
51. 1,7-Di-tert-butyl-Substituted aza-BODIPYs by low-barrier rotation to enhance a photothermal-photodynamic effect10.1002/chem.202103571 ↗
52. Synthesis of aza-BODIPYs with barrier-free rotation of the –tBu group at 3-site and enhancement of photothermal therapy by triggering cancer cell apoptosis10.1039/D2TB01513G ↗
53. Recent advances in noble metal complex based photodynamic therapy10.1039/D1SC05478C ↗
54. Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment
55. The triplet excited state of Bodipy: formation, modulation and application10.1039/C5CS00364D ↗
56. Frisch · 2009
57. Why do TD-DFT excitation energies of BODIPY/Aza-BODIPY families largely deviate from experiment? Answers from electron correlated and multireference methods10.1021/ct500775r ↗
58. β-Formyl-BODIPYs from the Vilsmeier−Haack reaction10.1021/jo901407h ↗
59. Discovery of a monoiodo aza-BODIPY near-infrared photosensitizer: in vitro and in vivo evaluation for photodynamic therapy10.1021/acs.jmedchem.0c00882 ↗